MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2217/fon-2022-1117

Медицинская библиотека · Future oncology (London, England) · 2023

Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer.

Zhang Yan, Doran Charlotte, Le Trong Kim, Dreyfus Brian, Kola Nina, Sylvester Brooke E, Lal Lincy, Penrod John R, Meadows Shropshire Stephanie

СтатьяПеревод в очереди

Аннотация

Aims: To describe, in patients with advanced/metastatic non-small-cell lung cancer, the relationship between baseline immunosuppressive drug (ISD)/corticosteroid (CS) use, as well as the incidence of mild/moderate adverse events (AEs), and the clinical effectiveness of PD (L)-1 blockade. Patients & methods: This was a retrospective cohort study of patients with no evidence (n = 131) or positive evidence (n = 269) of ISD/CS use.

Results

Duration of treatment, time to next treatment, progression-free survival and overall survival were significantly reduced for patients with evidence of prior ISD/CS use. Occurrence of mild/moderate AEs did not affect any clinical outcomes.

Conclusion

Prior ISD/CS use was associated with a poorer prognosis in advanced/metastatic non-small-cell lung cancer patients treated with PD-(L)1 inhibitors, but the occurrence of AEs had no effect.

Для цитирования: Zhang Yan, Doran Charlotte, Le Trong Kim, Dreyfus Brian, Kola Nina, Sylvester Brooke E, Lal Lincy, Penrod John R, Meadows Shropshire Stephanie. Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer.. Future oncology (London, England). 2023. DOI: 10.2217/fon-2022-1117.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.